EGFR and breast carcinoma: Cationic lipids induce the release of EGF+ EVs from melanoma cell lines [128], while breast cancer cells are known to respond to hypoxia by secreting increased numbers of sEVs, a mechanism that favours the secretion of EGFR ligands such as HB-EGF [129].